Elder Pharmaceuticals clarifies on news item

11 Sep 2015 Evaluate

With reference to the news reported in Mint, 11/09/2015-‘Elder Pharma to sell assets to clear debt’, Elder Pharmaceuticals has clarified that the Company had always promptly informed / intimated to the BSE /NSE all the events, information etc. which have a bearing on operation / performance of the Company including all price sensitive information pursuant to clause 36 of the listing agreement. At present, the Company is in the process of restructuring as a whole and hence is under advance negotiation/discussions with prospective lenders who would be interested in this exercise for the Company’s revival and as such no final formal agreement has been signed off from our end. They shall definitely inform the exchanges as soon as the final decision is taken by the board well in advance, with regard to the financial arrangement that may happen and shall keep you also informed the events that might take place in its entirety. At this juncture, they would like to inform that the company is not fully aware of the statements published in the article referred above. However, they will strictly adhere to clause 36 of listing agreement and shall promptly inform you the developments that may happen in this regard. They are therefore, unable to comment upon the variation in the prices and the volumes on the exchanges.

The above information is a part of company’s filings submitted to BSE.

 

Peers
Company Name CMP
Sun Pharma Inds. 1508.40
Dr. Reddys Lab 6332.85
Cipla 1424.40
Zydus Lifesciences 992.00
Lupin 1663.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.